Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer — iMAGINE

Colon Cancer Stage III Clinical Trial

Official title:
iMmunoscore Associated Decision GuIdance for adjuvaNt Chemotherapy and Physical Exercise in Stage III Colon Cancer (iMAGINE): a Prospective, Randomized, Open-label, Multicenter, Phase III Clinical Trial

Status Not yet recruiting

Clinical Trial Summary

The overall aim of this study is to prospectively validate the superiority of the Immunoscore as a decision guidance for adjuvant chemotherapy in stage III colon cancer patients, in comparison to the conventional TNM-based high- or low-risk classification.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04488159
Study type	Interventional
Source	Medical University of Vienna
Contact	Johannes Laengle, MD, PhD
Phone	+43 1 40400 69260
Email	johannes.laengle@meduniwien.ac.at
Status	Not yet recruiting
Phase	Phase 3
Start date	December 1, 2024
Completion date	June 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Completed	`NCT00309530` - Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C	Phase 3
Completed	`NCT04342676` - Lymph Node Ratio and Kras Mutation in R Colon Cancer	Phase 3
Enrolling by invitation	`NCT05179889` - Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer	Phase 2/Phase 3
Withdrawn	`NCT05433402` - Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer	Phase 1/Phase 2
Recruiting	`NCT06108310` - ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Withdrawn	`NCT05310565` - The Effects of Chiropractic in Adults With Colon Cancer	N/A
Recruiting	`NCT05194878` - Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers	Phase 3